Molecular Diagnostics News and Research

RSS

New test may improve the ability to diagnose riskiest forms of HPV infection

Ninety-nine percent of cervical cancers are caused by human papillomavirus (HPV). More than 200 HPVs, some of which are associated with varying degrees of cancer risk, complicate diagnosis and treatment.

12 Aug 2019

Groundbreaking study reveals how transgender hormone therapy affects medical test results

Groundbreaking research presented at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo has revealed how transgender hormone therapy affects the results of common laboratory tests in the long term.

6 Aug 2019

Research findings could help identify Alzheimer's patients who will benefit from exercise

A novel study has discovered metabolites that predict which Alzheimer's patients are likely to see their symptoms improve with exercise therapy.

6 Aug 2019

Questionnaire-based algorithm predicts preeclampsia risk in pregnant woman

Research presented today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo shows that a questionnaire-based algorithm predicts the risk of a pregnant woman developing preeclampsia.

6 Aug 2019

Researchers investigate impact of low-salt diets and ketogenic diet

Researchers have developed a novel test that identifies individuals who are the most likely to experience negative health effects if they eat a high salt diet.

5 Aug 2019

Preliminary study for detection of pancreatic cancer shows encouraging results

OTraces, Inc., a molecular diagnostics company specializing in early cancer detection, has announced completion of a preliminary study for detection of pancreatic cancer.

1 Aug 2019

MSK receives approval for new molecular assay from New York State Department of Health

Memorial Sloan Kettering Cancer Center announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status.

24 Jun 2019

BD launches automated solution for high throughput molecular diagnostic testing

BD, a leading global medical technology company, today announced the CE-IVDD certification of the BD COR System in Europe.

20 Jun 2019

Engineers crack the code to quickly diagnose anti-malarial drug resistance

One of the keys to quickly diagnosing anti-malarial drug resistance -- potentially saving lives -- lies in testing whole blood instead of extracting DNA, eliminating processing steps that can take hours or days.

13 Jun 2019

New assay uses a drop of blood to detect patients' resistance to antimalarial drugs

Antimalarial drugs appear to follow a typical pattern, with early effectiveness eventually limited by the emergence of drug resistance.

13 Jun 2019

AMP offers recommendations to aid in design and validation of clinical CYP2C9 assays

The Association for Molecular Pathology, the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations to aid in the design and validation of clinical CYP2C9 assays, promote standardization of testing across different laboratories and improve patient care.

10 May 2019

New genetic test identifies many disease-causing gene variations in high-risk populations

Researchers at Nemours Children's Health System have developed a new low-cost genetic test that accurately identified more than 200 known disease-causing gene variations in two high-risk populations, the Old Order Amish and Old Order Mennonites of Lancaster County, Pennsylvania.

25 Apr 2019

Making Laboratories More Efficient with the Most Modern LIMS on the Market

In this interview, Robert Voelkner, Vice President of Sales and Marketing at LabVantage Soultions talks to News-Medical about their new product the LabVantage 8.4 LIMS.

From LabVantage Solutions 24 Apr 2019

Microbiome science may help doctors to improve treatment for children with IBS

To improve the treatment of children with irritable bowel syndrome, investigators have developed a sophisticated way to analyze the microbial and metabolic contents of the gut.

17 Apr 2019

Spotlight on ECCMID 2019: Detecting Disease & Managing Infections

This article covers some of the highlights of ECCMID 2019, with insights into some of the companies and products being featured at the event.

From ESCMID 15 Apr 2019

High Throughput Nucleic Acid Purification Simplified

Labs demand purity and flexibility for high throughput nucleic acid purification, while needing to complete difficult downstream analysis, for example NGS.

From Promega Corporation 9 Apr 2019

Horizon Discovery partners with St George’s University Hospital and EMQN to develop reference material for NIPT

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced it is collaborating with St George’s University Hospital, London, and the European Molecular Genetics Quality Network (EMQN), based within the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, to develop reference material for non-invasive prenatal testing (NIPT).

From Revvity 26 Mar 2019

Shaping new treatments for tuberculosis

To commemorate World TB Day, a Special Collection has been released by PLOS Medicine containing a series of articles that articulate the essential new steps in clinical research that will pave the way for the development of tomorrow's optimal treatment for all forms of tuberculosis.

25 Mar 2019

Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics

Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.

22 Mar 2019

Study proposes new approach that cures multidrug-resistant TB in conflict-affected communities

A high proportion of multidrug-resistant tuberculosis cases can be cured in conflict-affected communities with molecular diagnostics, shorter treatment periods and socioeconomic incentives, according to the results of a large, long-term study in the Democratic Republic of Congo led by the University of Pittsburgh Graduate School of Public Health and Stellenbosch University in South Africa, in collaboration with the DRC National Tuberculosis Program.

14 Feb 2019

Molecular Diagnostics News and Research

New test may improve the ability to diagnose riskiest forms of HPV infection

Groundbreaking study reveals how transgender hormone therapy affects medical test results

Research findings could help identify Alzheimer's patients who will benefit from exercise

Questionnaire-based algorithm predicts preeclampsia risk in pregnant woman

Researchers investigate impact of low-salt diets and ketogenic diet

Preliminary study for detection of pancreatic cancer shows encouraging results

MSK receives approval for new molecular assay from New York State Department of Health

BD launches automated solution for high throughput molecular diagnostic testing

Engineers crack the code to quickly diagnose anti-malarial drug resistance

New assay uses a drop of blood to detect patients' resistance to antimalarial drugs

AMP offers recommendations to aid in design and validation of clinical CYP2C9 assays

New genetic test identifies many disease-causing gene variations in high-risk populations

Making Laboratories More Efficient with the Most Modern LIMS on the Market

Microbiome science may help doctors to improve treatment for children with IBS

Spotlight on ECCMID 2019: Detecting Disease & Managing Infections

High Throughput Nucleic Acid Purification Simplified

Horizon Discovery partners with St George’s University Hospital and EMQN to develop reference material for NIPT

Shaping new treatments for tuberculosis

Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics

Study proposes new approach that cures multidrug-resistant TB in conflict-affected communities

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News